Search - tctmd.com

Displaying 881 - 900 of 1661

Sort: Relevancy | Date

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Pedro A. Lemos

October 31, 2017

Presentation TCT 2017

Devices - Needles, Wires and Sheaths

Presenter: Paul Sorajja

October 31, 2017

Presentation TCT 2017

Case Presentation: A Patient With Multivessel Disease in STEMI

Presenter: Stefan K. James, Ran Kornowski, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Registry Update: GABI-R

Presenter: Stephen G. Ellis, Takeshi Kimura, Holger M. Nef

October 31, 2017

Presentation TCT 2017

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roberto Botelho

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB UK

Presenter: Stephen G. Ellis, Takeshi Kimura, Mark A. de Belder

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Deepak L. Bhatt

October 31, 2017

Presentation TCT 2017

The Combo Stent: From Concept to Clinical Performance

Presenter: Manel Sabate, Joanna J. Wykrzykowska, Roxana Mehran

October 31, 2017

Presentation TCT 2017

Registry Update: ABSORB Extend At 3 Years

Presenter: Stephen G. Ellis, Takeshi Kimura, Antonio L. Bartorelli

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Thomas Engstroem

October 31, 2017

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Presenter: Stefan K. James, Ran Kornowski, Jacob Lønborg, MD

October 31, 2017

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Case Presentation: No Reflow After Primary PCI

Presenter: David P. Faxon, Robert S. Schwartz, Mohamed Abdel-Wahab

October 31, 2017

Presentation TCT 2017

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres

October 31, 2017

Presentation TCT 2017

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Presenter: David P. Faxon, Robert S. Schwartz, Stefan K. James

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Advertisement

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 2: Inspiron

Devices - Needles, Wires and Sheaths

Case Presentation: A Patient With Multivessel Disease in STEMI

Registry Update: GABI-R

Outcomes With a Thin-Strut PLLA-Based Sirolimus-Eluting Stent 1: Biomime

Registry Update: ABSORB UK

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Watchful Waiting Is the Preferred Strategy!

The Combo Stent: From Concept to Clinical Performance

Registry Update: ABSORB Extend At 3 Years

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Case Presentation: No Reflow After Primary PCI

Case #4: Paravalvular Leak Closure Using a Multifunctional Occluder Device

Manual Aspiration Thrombectomy in STEMI: Do Any Subgroups Benefit?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content